Viatris registers Phase 4 abuse-potential trial of gabapentin plus oxycodoneSep 10Trial updategabapentinoxycodone
Viatris: Ocuphire trial results posted, Amnesteem label update, gabapentin abuse study completedAug 21Weekly roundup, 3 itemsalprazolamgabapentin
FDA approves labeling supplement for Zydus gabapentin ANDAJul 17Regulatory decisiongabapentinZydus Lifesciences
Sign inSign in